Citation: S. Bastujigarin, FUNDAMENTAL-CONCEPTS OF EPIDEMIOLOGY USEF UL FOR DERMATOLOGISTS, Annales de dermatologie et de venereologie, 125(1), 1998, pp. 65-70
Authors:
BASTUJIGARIN S
TURKI H
MOKHTAR I
NOUIRA R
FAZAA B
JOMAA B
ZAHAF A
BENOSMAN A
SOUISSI R
REVUZ J
ROUJEAU JC
KAMOUN MR
Citation: S. Bastujigarin et al., RISK-FACTORS OF TUNISIAN PEMPHIGUS - A CASE-CONTROL STUDY, Journal of investigative dermatology, 110(4), 1998, pp. 590-590
Authors:
MANSOURI S
DUBERTRET L
BASTUJIGARIN S
DOMBRET H
ROUJEAU JC
ARACTINGI S
Citation: S. Mansouri et al., ROLE OF DRUGS IN CUTANEOUS ERUPTIONS AFTER CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA, Archives of dermatology, 134(7), 1998, pp. 881-882
Authors:
ROUJEAU JC
LOK C
BASTUJIGARIN S
MHALLA S
ENGINGER V
BERNARD P
Citation: Jc. Roujeau et al., HIGH-RISK OF DEATH IN ELDERLY PATIENTS WITH EXTENSIVE BULLOUS PEMPHIGOID, Archives of dermatology, 134(4), 1998, pp. 465-469
Citation: S. Bastujigarin, WHY DO REPORTINGS IN PHARMACOVIGILANCE AN D CASE-CONTROL STUDIES PROVIDE DIFFERENT RESULTS IN DRUG-REACTIONS, IN BULLOUS PEMPHIGOID, Annales de dermatologie et de venereologie, 124(11), 1997, pp. 824-825
Authors:
DUPUY A
BENCHIKHI H
BASTUJIGARIN S
DANG PM
SASSOLAS B
CHOSIDOW O
VAILLANT L
GUILLAUME JC
GROB JJ
ROUJEAU JC
Citation: A. Dupuy et al., RISK-FACTORS OF LEG ERYSIPELA - A MULTICENTRIC CASE-CONTROL STUDY, Journal of investigative dermatology, 108(3), 1997, pp. 12-12
Authors:
POPOV Z
HOZNEK A
COLOMBEL M
BASTUJIGARIN S
LEFREREBELDA MA
BELLOT J
ABBOU GC
MAZEROLLES C
CHOPIN DK
Citation: Z. Popov et al., THE PROGNOSTIC VALUE OF P53 NUCLEAR OVEREXPRESSION AND MIB-1 AS A PROLIFERATIVE MARKER IN TRANSITIONAL-CELL CARCINOMA OF THE BLADDER, Cancer, 80(8), 1997, pp. 1472-1481
Authors:
DURANDZALESKI I
BASTUJIGARIN S
ZALESKI S
WEIL B
ROSTOKER G
Citation: I. Durandzaleski et al., A COST-ANALYSIS OF THE PREVENTION OF END-STAGE RENAL-DISEASE - IMMUNOGLOBULIN THERAPY FOR IGA NEPHROPATHY, Medical decision making, 16(4), 1996, pp. 326-334
Authors:
BASTUJIGARIN S
SOUISSI R
BLUM L
TURKI H
NOUIRA R
JOMAA B
ZAHAF A
BENOSMAN A
MOKHTAR I
FAZAA B
REVUZ J
ROUJEAU JC
KAMOUN MR
Citation: S. Bastujigarin et al., COMPARATIVE EPIDEMIOLOGY OF PEMPHIGUS IN TUNISIA AND FRANCE - UNUSUALINCIDENCE OF PEMPHIGUS FOLIACEUS IN YOUNG TUNISIAN WOMEN, Annales de dermatologie et de venereologie, 123(5), 1996, pp. 337-342
Authors:
GROB JJ
BASTUJIGARIN S
VAILLANT L
ROUJEAU JC
BERNARD P
SASSOLAS B
GUILLAUME JC
Citation: Jj. Grob et al., EXCESS OF NEVI RELATED TO IMMUNODEFICIENCY - A STUDY IN HIV-INFECTED PATIENTS AND RENAL-TRANSPLANT RECIPIENTS, Journal of investigative dermatology, 107(5), 1996, pp. 694-697
Authors:
CORDONNIER C
BASTUJIGARIN S
VEIL A
CONYMAKHOUL P
HERBRECHT R
HUNAULT M
BENDAHMANE B
TIAB M
LEVERGER G
Citation: C. Cordonnier et al., EPIDEMIOLOGY AND RISK-FACTORS FOR GRAM PLUS INFECTIONS IN NEUTROPENICPATIENTS - A PROSPECTIVE-STUDY IN HEMATOLOGY UNITS, Blood, 88(10), 1996, pp. 318-318
Authors:
ASSIER H
BASTUJIGARIN S
REVUZ J
ROUJEAU JC
Citation: H. Assier et al., ERYTHEMA MULTIFORME WITH MUCOUS-MEMBRANE INVOLVEMENT AND STEVENS-JOHNSON SYNDROME ARE CLINICALLY DIFFERENT DISORDERS - REPLY, Archives of dermatology, 132(6), 1996, pp. 711-712
Authors:
WOLKENSTEIN P
CARRIERE V
CHARUE D
BASTUJIGARIN S
REVUZ J
ROUJEAU JC
BEAUNE P
BAGOT M
Citation: P. Wolkenstein et al., A SLOW ACETYLATOR GENOTYPE IS A RISK FACTOR FOR SULFONAMIDE-INDUCED TOXIC EPIDERMAL NECROLYSIS AND STEVENS-JOHNSON SYNDROME, Pharmacogenetics, 5(4), 1995, pp. 255-258
Authors:
FOURNIER S
BASTUJIGARIN S
MENTEC H
REVUZ J
ROUJEAU JC
Citation: S. Fournier et al., TOXIC EPIDERMAL NECROLYSIS ASSOCIATED WITH MYCOPLASMA-PNEUMONIAE INFECTION, European journal of clinical microbiology & infectious diseases, 14(6), 1995, pp. 558-559
Authors:
KELLY JP
AUQUIER A
RZANY B
NALDI L
BASTUJIGARIN S
CORREIA O
SHAPIRO S
KAUFMAN DW
Citation: Jp. Kelly et al., AN INTERNATIONAL COLLABORATIVE CASE-CONTROL STUDY OF SEVERE CUTANEOUSADVERSE REACTIONS (SCAR) - DESIGN AND METHODS, Journal of clinical epidemiology, 48(9), 1995, pp. 1099-1108
Authors:
ROUJEAU JC
KELLY JP
NALDI L
RZANY B
STERN RS
ANDERSON T
AUQUIER A
BASTUJIGARIN S
CORREIA O
LOCATI F
MOCKENHAUPT M
PAOLETTI C
SHAPIRO S
SHEAR N
SCHOPF E
KAUFMAN DW
Citation: Jc. Roujeau et al., MEDICATION USE AND THE RISK OF STEVENS-JOHNSON SYNDROME OR TOXIC EPIDERMAL NECROLYSIS, The New England journal of medicine, 333(24), 1995, pp. 1600-1607
Authors:
BASTUJIGARIN S
SOUISSI R
BLUM L
TURKI H
NOUIRA R
JOMAA B
ZAHAF A
BENOSMAN A
MOKHTAR I
FAZAA B
REVUZ J
ROUJEAU JC
KAMOUN MR
Citation: S. Bastujigarin et al., COMPARATIVE EPIDEMIOLOGY OF PEMPHIGUS IN TUNISIA AND FRANCE - UNUSUALINCIDENCE OF PEMPHIGUS FOLIACEUS IN YOUNG TUNISIAN WOMEN, Journal of investigative dermatology, 104(2), 1995, pp. 302-305
Authors:
GUIBAL F
BASTUJIGARIN S
CHOSIDOW O
SAIAG P
REVUZ J
ROUJEAU JC
Citation: F. Guibal et al., CHARACTERISTICS OF TOXIC EPIDERMAL NECROLYSIS IN PATIENTS UNDERGOING LONG-TERM GLUCOCORTICOID THERAPY, Archives of dermatology, 131(6), 1995, pp. 669-672
Authors:
ASSIER H
BASTUJIGARIN S
REVUZ J
ROUJEAU JC
Citation: H. Assier et al., ERYTHEMA MULTIFORME WITH MUCOUS-MEMBRANE INVOLVEMENT AND STEVENS-JOHNSON SYNDROME ARE CLINICALLY DIFFERENT DISORDERS WITH DISTINCT CAUSES, Archives of dermatology, 131(5), 1995, pp. 539-543
Authors:
PARNEIXSPAKE A
BASTUJIGARIN S
LOBUT JB
ERNER J
GUYETROUSSET P
REVUZ J
ROUJEAU JC
Citation: A. Parneixspake et al., MINOCYCLINE AS POSSIBLE CAUSE OF SEVERE AND PROTRACTED HYPERSENSITIVITY DRUG REACTION, Archives of dermatology, 131(4), 1995, pp. 490-491
Authors:
COTE B
WECHSLER J
BASTUJIGARIN S
ASSIER H
REVUZ J
ROUJEAU JC
Citation: B. Cote et al., CLINICOPATHOLOGICAL CORRELATION IN ERYTHEMA MULTIFORME AND STEVENS-JOHNSON SYNDROME, Archives of dermatology, 131(11), 1995, pp. 1268-1272
Authors:
CHOSIDOW O
CHASTANG C
BRUE C
BOUVET E
IZRI M
MONTENY N
BASTUJIGARIN S
ROUSSET JJ
REVUZ J
Citation: O. Chosidow et al., CONTROLLED-STUDY OF MALATHION AND D-PHENOTHRIN LOTIONS FOR PEDICULUS-HUMANUS VAR CAPITIS-INFESTED SCHOOLCHILDREN, Lancet, 344(8939-4), 1994, pp. 1724-1727
Authors:
OCHONISKY S
VERROUST J
BASTUJIGARIN S
GHERARDI R
REVUZ J
Citation: S. Ochonisky et al., THALIDOMIDE NEUROPATHY INCIDENCE AND CLINICOELECTROPHYSIOLOGIC FINDINGS IN 42 PATIENTS, Archives of dermatology, 130(1), 1994, pp. 66-69